Zobrazeno 1 - 10
of 25
pro vyhledávání: '"F.R. Leus"'
Autor:
Martin Wolkewitz, Surbhi Malhotra-Kumar, Kim Gilchrist, F.R. Leus, Maja von Cube, Irith Wiegand, Jesús Rodríguez-Baño, Michael P. McCarthy, Jérôme Robert, Abdel Oualim, Marlieke E. A. de Kraker, Frangiscos Sifakis, Maaike S. M. van Mourik, Andreas Voss, Harriet Sommer, Julia Bielicki, Jessica Price, Evelina Tacconelli, Cuong Vuong, Remco Schrijver, Giuseppe Marasca, María Núñez-Núñez, Sumanth Gandra, Christine Luxemburger, Herman Goossens, Beryl Primrose Gladstone, Achilleas Gikas, Nithya Babu Rajendran, María Dolores González-Ripoll Navarro, Anne Therese Witschi, Petra Gastmeier, Gunnar Kahlmeter, Hasan S. Jafri, Stéphan Juergen Harbarth, Mike Sharland
Publikováno v:
Lancet Infectious Diseases, 18, E99-E106
Lancet Infectious Diseases, 18, 3, pp. E99-E106
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2018, 18 (3), pp.e99-e106. ⟨10.1016/S1473-3099(17)30485-1⟩
The lancet infectious diseases
The Lancet Infectious Diseases, Vol. 18, No 3 (2018) pp. e99-e106
Lancet Infectious Diseases, 18, 3, pp. E99-E106
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2018, 18 (3), pp.e99-e106. ⟨10.1016/S1473-3099(17)30485-1⟩
The lancet infectious diseases
The Lancet Infectious Diseases, Vol. 18, No 3 (2018) pp. e99-e106
Antimicrobial resistance poses a growing threat to public health and the provision of health care. Its surveillance should provide up-to-date and relevant information to monitor the appropriateness of therapy guidelines, antibiotic formulary, antibio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fbfd306f5856051735901d7d37d1f68
https://hdl.handle.net/10668/11766
https://hdl.handle.net/10668/11766
Autor:
F.R. Leus, Hieronymus A.M. Voorbij, John J.P. Kastelein, Arjan D. Barendrecht, Mark Roest, Angelique C.M. Jansen
Publikováno v:
Clinical biochemistry, 38(2), 123-127. Elsevier Inc.
Objectives: Paraoxonase (PON1) is a potent enzyme, physically associated with the high-density lipoprotein particle. PON1 may protect against cardiovascular disease (CVD), since it is capable of hydrolyzing oxidized LDL-cholesterol, thereby negating
Publikováno v:
Thrombosis and Haemostasis. 82:1709-1717
SummaryLipoprotein (a) [Lp(a)] is a quantitative genetic trait in human plasma and elevated levels represent a major inherited risk factor for the development of atherosclerotic disease. In our search for sequence polymorphisms in the coding region o
Autor:
H. J. M. Van Rijn, F.R. Leus, J. Prins, Bonno N. Bouma, Y. Y. Van Der Hoek, J. J. P. Kastelein
Publikováno v:
Thrombosis and Haemostasis. 77:0949-0954
SummaryElevated plasma levels of lipoprotein(a) [Lp(a)] represent a significant independent risk factor for the development of atherosclerosis. Interindividual levels of apo(a) vary over 1000-fold and are mainly due to inheritance that is linked to t
Autor:
Kalina T. Zlateva, Marco C. Viveen, Margareta Ieven, Eric C. J. Claas, Alexander E. Gorbalenya, F.R. Leus, Frank E. J. Coenjaerts, Kelly M. Crusio, Willy J. M. Spaan, Christine Lammens
Publikováno v:
Archives of virology
Archives of Virology, 158(1), 251-255
Archives of Virology
Archives of Virology, 158(1), 251-255
Archives of Virology
Novel viruses might be responsible for numerous disease cases with unknown etiology. In this study, we screened 1800 nasopharyngeal samples from adult outpatients with respiratory disease symptoms and healthy individuals. We employed a reverse transc
Publikováno v:
Fibrinolysis. 10:317-324
Summary Elevated plasma levels of lipoprotein (a) (Lp(a)) in humans represent a major inherited risk factor for atherosclerosis. Lp(a) consists of a LDL-like particle with an additional glycoprotein, apolipoprotein(a) (apo(a)), linked to apolipoprote
Publikováno v:
Clinical Biochemistry. 27:449-455
Three commercially available assays (an enzyme-linked immunosorbent assay ELISA, an immunoradiometric assay, IRMA, and a nephelometric assay) for the determination of lipoprotein(a) [Lp(a)] were compared with respect to the dependency of these assays
Autor:
P.F.C.C.M. Duif, C.B. Leerink, H. J. M. Van Rijn, F.R. Leus, Christian M. Hackeng, Bonno N. Bouma, J. Prins, N. Verhoeven
Publikováno v:
Fibrinolysis. 8:214-220
Lipoprotein(a) (Lp(a)) is a LDL-like particle with an additional glycoprotein, apo(a), linked to apolipoprotein B-100. Apo(a) is highly homologous to parts of the plasminogen molecule, and numerous investigations have shown interference of Lp(a) with
Autor:
Marja E. Jakobs, Martijn D. B. van de Garde, Herman Goossens, Michel de Vries, Frank E. J. Coenjaerts, Christine Lammens, Martin Deijs, Richard Molenkamp, Barbera D. C. van Schaik, Loes C. M. Jachimowski, Maarten F. Jebbink, Margareta Ieven, Marta Canuti, Lia van der Hoek, F.R. Leus, Frank Baas, Nuno R. Faria, Sylvie M. Koekkoek, Angela C. M. Luyf, Eric C. J. Claas
Publikováno v:
PLoS ONE, 6(1):e16118. Public Library of Science
PLoS ONE
PLoS ONE, 6(1)
PLoS ONE; Vol 6
PLoS ONE, Vol 6, Iss 1, p e16118 (2011)
PLoS ONE, 6(1). Public Library of Science
PLoS ONE
PLoS ONE, 6(1)
PLoS ONE; Vol 6
PLoS ONE, Vol 6, Iss 1, p e16118 (2011)
PLoS ONE, 6(1). Public Library of Science
In 540% of respiratory infections in children, the diagnostics remain negative, suggesting that the patients might be infected with a yet unknown pathogen. Virus discovery cDNA-AFLP (VIDISCA) is a virus discovery method based on recognition of restri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0553f38af256a65f3d04529d5e7002f
https://dare.uva.nl/personal/pure/en/publications/a-sensitive-assay-for-virus-discovery-in-respiratory-clinical-samples(d1c36eaf-2804-45ef-b65e-f9944c66e567).html
https://dare.uva.nl/personal/pure/en/publications/a-sensitive-assay-for-virus-discovery-in-respiratory-clinical-samples(d1c36eaf-2804-45ef-b65e-f9944c66e567).html
Publikováno v:
Atherosclerosis, 149(2), 371-377. Elsevier Ireland Ltd
Human serum paraoxonase (PON) is a high density lipoprotein (HDL) associated enzyme capable of hydrolyzing lipid peroxides in vitro. PON has recently attracted attention as a protective factor against oxidative modification of LDL and may therefore p